Capstone Investment Advisors LLC Has $492,000 Position in Core Scientific, Inc. (NASDAQ:CORZ)

Capstone Investment Advisors LLC lessened its holdings in Core Scientific, Inc. (NASDAQ:CORZ) by 36.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 35,000 shares of the company’s stock after selling 20,000 shares during the period. Capstone Investment Advisors LLC’s holdings in Core Scientific were worth $492,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Core Scientific by 54.3% in the 4th quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock valued at $272,270,000 after acquiring an additional 6,819,406 shares during the period. Beryl Capital Management LLC grew its stake in shares of Core Scientific by 24.3% in the fourth quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company’s stock valued at $255,423,000 after acquiring an additional 3,548,396 shares in the last quarter. ORG Wealth Partners LLC raised its stake in Core Scientific by 0.3% in the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after purchasing an additional 26,649 shares in the last quarter. FMR LLC raised its stake in Core Scientific by 2,937.7% in the 4th quarter. FMR LLC now owns 7,436,229 shares of the company’s stock worth $104,479,000 after purchasing an additional 7,191,428 shares in the last quarter. Finally, Two Seas Capital LP grew its position in shares of Core Scientific by 9.2% during the 4th quarter. Two Seas Capital LP now owns 6,232,888 shares of the company’s stock worth $87,572,000 after purchasing an additional 527,097 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research firms have commented on CORZ. Needham & Company LLC lowered their price objective on Core Scientific from $18.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, February 27th. Craig Hallum initiated coverage on Core Scientific in a research report on Tuesday, January 21st. They set a “buy” rating and a $24.00 price objective for the company. Keefe, Bruyette & Woods assumed coverage on Core Scientific in a research report on Monday, January 27th. They issued an “outperform” rating and a $22.00 target price on the stock. Cantor Fitzgerald dropped their price objective on shares of Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Finally, Compass Point decreased their target price on shares of Core Scientific from $26.00 to $20.00 and set a “buy” rating on the stock in a research note on Tuesday, February 25th. Fifteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Core Scientific presently has an average rating of “Buy” and a consensus target price of $19.07.

Insider Activity at Core Scientific

In other news, Director Todd A. Becker sold 134,250 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the transaction, the director now owns 195,687 shares in the company, valued at approximately $2,103,635.25. The trade was a 40.69 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jordan Levy acquired 62,500 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were purchased at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the transaction, the director now owns 306,887 shares of the company’s stock, valued at $2,458,164.87. This trade represents a 25.57 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by company insiders.

Core Scientific Stock Up 0.1 %

Shares of Core Scientific stock opened at $8.75 on Tuesday. The stock has a market cap of $2.58 billion, a price-to-earnings ratio of -1.62 and a beta of 6.66. Core Scientific, Inc. has a twelve month low of $3.29 and a twelve month high of $18.63. The company’s fifty day moving average is $8.02 and its 200 day moving average is $12.18.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million. As a group, equities analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current fiscal year.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.